GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sharecare Inc (NAS:SHCR) » Definitions » ROE %

Sharecare (Sharecare) ROE % : -31.05% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Sharecare ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Sharecare's annualized net income for the quarter that ended in Dec. 2023 was $-137.0 Mil. Sharecare's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $441.1 Mil. Therefore, Sharecare's annualized ROE % for the quarter that ended in Dec. 2023 was -31.05%.

The historical rank and industry rank for Sharecare's ROE % or its related term are showing as below:

SHCR' s ROE % Range Over the Past 10 Years
Min: -31.06   Med: -27.01   Max: -21.89
Current: -27.1

During the past 5 years, Sharecare's highest ROE % was -21.89%. The lowest was -31.06%. And the median was -27.01%.

SHCR's ROE % is ranked worse than
79.74% of 612 companies
in the Healthcare Providers & Services industry
Industry Median: 4.035 vs SHCR: -27.10

Sharecare ROE % Historical Data

The historical data trend for Sharecare's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sharecare ROE % Chart

Sharecare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
- - -31.06 -21.89 -27.01

Sharecare Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.27 -27.25 -29.08 -21.20 -31.05

Competitive Comparison of Sharecare's ROE %

For the Health Information Services subindustry, Sharecare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sharecare's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sharecare's ROE % distribution charts can be found below:

* The bar in red indicates where Sharecare's ROE % falls into.



Sharecare ROE % Calculation

Sharecare's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-128.498/( (521.445+430.136)/ 2 )
=-128.498/475.7905
=-27.01 %

Sharecare's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-136.98/( (452.133+430.136)/ 2 )
=-136.98/441.1345
=-31.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Sharecare  (NAS:SHCR) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-136.98/441.1345
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-136.98 / 421.104)*(421.104 / 621.6165)*(621.6165 / 441.1345)
=Net Margin %*Asset Turnover*Equity Multiplier
=-32.53 %*0.6774*1.4091
=ROA %*Equity Multiplier
=-22.04 %*1.4091
=-31.05 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-136.98/441.1345
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-136.98 / -137.004) * (-137.004 / -141.816) * (-141.816 / 421.104) * (421.104 / 621.6165) * (621.6165 / 441.1345)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9998 * 0.9661 * -33.68 % * 0.6774 * 1.4091
=-31.05 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Sharecare ROE % Related Terms

Thank you for viewing the detailed overview of Sharecare's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sharecare (Sharecare) Business Description

Traded in Other Exchanges
Address
255 East Paces Ferry Road NE, Suite 700, Atlanta, GA, USA, 30305
Sharecare Inc is a digital healthcare platform company that helps members consolidate and manage various components of their health in one place, regardless of their health journey. Its platform offers an accessible, interactive, personalized, and rewarding environment that aims to transform user engagement with healthcare from episodic to every day. The platform provides a single destination for people, patients, and caregivers to access quality and clinically reviewed content; digitally connect with other patients, community members, and healthcare professionals; and adopt action plans provided by healthcare professionals from top institutions.
Executives
Brent D Layton director 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63130
Michael Blalock officer: Chief Accounting Officer C/O SHARECARE, INC., 255 E. PACES FERRY RD. NE, SUITE 700, ATLANTA GA 30305
Carrie Ratliff officer: Chief Legal Officer C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Jaffry Mohammed officer: Chief Operating Officer C/O SHARECARE, INC., 255 E. PACES FERRY RD. NE, SUITE 700, ATLANTA GA 30305
Jeffrey Sagansky director 1450 2ND STREET, SUITE 247, SANTA MONICA CA 90401
Kenneth R Goulet director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Sandro Galea director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Veronica Mallett director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
John Huston Chadwick director, other: Affiliate of 10% owner C/O CLARITAS CAPITAL, 30 BURTON HILLS BOULEVARD, SUITE 100, NASHVILLE TN 37215
Jeffrey A Allred director C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Alan G. Mnuchin director 2121 AVENUE OF THE STARS, SUITE 2300, LOS ANGELES CA 90067
Jeffrey T Arnold director, 10 percent owner, officer: CEO and Chairman C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Dawn Whaley officer: President, CMO C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Justin Ferrero officer: President, CFO C/O SHARECARE, INC., 255 EAST PACES FERRY ROAD NE, SUITE 700, ATLANTA GA 30305
Claritas Sc Bactes Partners, Llc other: Affiliate of 10% Owner 30 BURTON HILLS BOULEVARD, SUITE 100, NASHVILLE TN 37215